Prevalence and Correlates of Severe Anxiety in Patients with First Hospitalization for Major Depressive Disorder Combined with Dyslipidemia: a Large Sample Cross-sectional Study

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2024 Feb 1

PMID 38298928

Authors

Huimin Yin

Qi Zhang

Yi Li

Jun Ma

Affiliations

Soon will be listed here.

Abstract

Background: Anxiety symptoms and dyslipidemia are common co-morbidities in patients with major depressive disorder (MDD), and there are complex pathophysiologic as well as clinical mechanisms underlying the association between the three. In this study, we investigated the prevalence and associated factors of severe anxiety in first-time hospitalized patients with MDD with dyslipidemia.

Methods: We included 708 patients with major depressive disorder with comorbid dyslipidemia and collected their sociodemographic and general clinical data as well as biochemical parameters such as lipids, thyroid function, and blood glucose. We also completed the Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), Positive Symptom Scale (PSS), and Clinical General Impression Scale (CGI) to assess their clinical symptoms.

Results: The prevalence of severe anxiety disorder was 11.02% in patients with MDD with comorbid dyslipidemia. Suicidal history, female gender, body mass index (BMI), HAMD score, PSS score, and FT level were risk factors for the development of severe anxiety symptoms. Higher HAMD scores, higher PSS scores, and suicidal history were influential factors in exacerbating severe anxiety symptoms.

Conclusion: This study reports and identifies the prevalence of severe anxiety symptoms in first-time hospitalized MDD patients with dyslipidemia, as well as risk factors for anxiety symptoms and factors influencing their severity, and these identified factors may be potentially helpful and informative in preventing and intervening in severe anxiety disorders in this target population.

Citing Articles

The relationship between weight-adjusted-waist index and suicidal ideation: evidence from NHANES.

Guo S, Qing G, Chen Q, Yang G Eat Weight Disord. 2024; 29(1):37.

PMID: 38743203 PMC: 11093856. DOI: 10.1007/s40519-024-01666-4.

References

Barbosa C, Merces M, Santana A, de Souza E Silva D, Pimentel R, Coelho J . Anxiety and dyslipidemia among primary health care professionals: A Cross-sectional study. Work. 2022; 71(3):739-748. DOI: 10.3233/WOR-205095. View

Yang W, Qu M, Jiang R, Lang X, Zhang X . Association between thyroid function and comorbid anxiety in first-episode and drug naïve patients with major depressive disorder. Eur Arch Psychiatry Clin Neurosci. 2022; 273(1):191-198. DOI: 10.1007/s00406-022-01457-x. View

Popova N, Tsybko A, Naumenko V . The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference. Int J Mol Sci. 2022; 23(15). PMC: 9369404. DOI: 10.3390/ijms23158814. View

Zhou Y, Wang Q, Ren H, Yang W, Ma Y, Wu Q . Prevalence and related factors of anxiety in first episode and drug naïve Chinese Han outpatients with psychotic major depression. J Affect Disord. 2022; 316:217-222. DOI: 10.1016/j.jad.2022.08.018. View

Yu D, Zhou H, Yang Y, Jiang Y, Wang T, Lv L . The bidirectional effects of hypothyroidism and hyperthyroidism on anxiety- and depression-like behaviors in rats. Horm Behav. 2015; 69:106-15. DOI: 10.1016/j.yhbeh.2015.01.003. View

Afzaal M, Saeed F, Shah Y, Hussain M, Rabail R, Socol C . Human gut microbiota in health and disease: Unveiling the relationship. Front Microbiol. 2022; 13:999001. PMC: 9549250. DOI: 10.3389/fmicb.2022.999001. View

Milaneschi Y, Simmons W, van Rossum E, Penninx B . Depression and obesity: evidence of shared biological mechanisms. Mol Psychiatry. 2018; 24(1):18-33. DOI: 10.1038/s41380-018-0017-5. View

Pompili M, Innamorati M, Erbuto D, Luciano M, Sampogna G, Abbate-Daga G . High depression symptomatology and mental pain characterize suicidal psychiatric patients. Eur Psychiatry. 2022; 65(1):e54. PMC: 9491079. DOI: 10.1192/j.eurpsy.2022.2312. View

Lopresti A, Hood S, Drummond P . A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. J Affect Disord. 2013; 148(1):12-27. DOI: 10.1016/j.jad.2013.01.014. View

10.

Yang W, Qu M, Fang H, Phan A, Wu H, Lang X . Gender differences in prevalence and clinical correlates of anxiety symptoms in first-episode and drug-naïve patients with major depressive disorder. Compr Psychiatry. 2021; 111:152275. DOI: 10.1016/j.comppsych.2021.152275. View

11.

Chen H, Wang X, Huang Y, Li G, Liu Z, Li Y . Prevalence, risk factors and multi-group latent class analysis of lifetime anxiety disorders comorbid depressive symptoms. J Affect Disord. 2018; 243:360-365. DOI: 10.1016/j.jad.2018.09.053. View

12.

Smits J, Minhajuddin A, Thase M, Jarrett R . Outcomes of acute phase cognitive therapy in outpatients with anxious versus nonanxious depression. Psychother Psychosom. 2012; 81(3):153-60. PMC: 3362240. DOI: 10.1159/000334909. View

13.

Lin P, Chang A, Lin T . Simvastatin treatment exerts antidepressant-like effect in rats exposed to chronic mild stress. Pharmacol Biochem Behav. 2014; 124:174-9. DOI: 10.1016/j.pbb.2014.06.006. View

14.

Fava M, Alpert J, Carmin C, Wisniewski S, Trivedi M, Biggs M . Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med. 2005; 34(7):1299-308. DOI: 10.1017/s0033291704002612. View

15.

Cieza A, Causey K, Kamenov K, Wulf Hanson S, Chatterji S, Vos T . Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10267):2006-2017. PMC: 7811204. DOI: 10.1016/S0140-6736(20)32340-0. View

16.

Gaspersz R, Nawijn L, Lamers F, Penninx B . Patients with anxious depression: overview of prevalence, pathophysiology and impact on course and treatment outcome. Curr Opin Psychiatry. 2017; 31(1):17-25. DOI: 10.1097/YCO.0000000000000376. View

17.

Montreuil T, Malla A, Joober R, Belanger C, Lepage M . Anxiety symptoms severity and short-term clinical outcome in first-episode psychosis. Early Interv Psychiatry. 2013; 7(1):5-11. DOI: 10.1111/eip.12018. View

18.

Mandrekar J . Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010; 5(9):1315-6. DOI: 10.1097/JTO.0b013e3181ec173d. View

19.

Fava M, Rush A, Alpert J, Balasubramani G, Wisniewski S, Carmin C . Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008; 165(3):342-51. DOI: 10.1176/appi.ajp.2007.06111868. View

20.

Fulton S, Decarie-Spain L, Fioramonti X, Guiard B, Nakajima S . The menace of obesity to depression and anxiety prevalence. Trends Endocrinol Metab. 2021; 33(1):18-35. DOI: 10.1016/j.tem.2021.10.005. View